First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
31 hedge funds and large institutions have $18.1M invested in First Trust Nasdaq Pharmaceuticals ETF in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$814K | |
| 2 | +$504K | |
| 3 | +$385K | |
| 4 |
WFA
WMG Financial Advisors
Knoxville,
Tennessee
|
+$297K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$220K |
Top Sellers
| 1 | -$4.76M | |
| 2 | -$1.23M | |
| 3 | -$550K | |
| 4 |
Goldman Sachs
New York
|
-$550K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$201K |